Endometrial Carcinoma
📧 Sign up to get email alerts when something new happens for Endometrial Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: FOG-001 in Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
FOG-001 is being studied in a Phase 1/2 trial across multiple locally advanced or metastatic solid tumors and is currently recruiting; indic…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial [Phase 1]
This is an early-stage (Phase 1) clinical trial evaluating the combination of DS-8201a (trastuzumab deruxtecan) and AZD6738 (camonsertib) fo…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence. [Phase 3]
Phase 3 clinical trial evaluating sentinel lymph node policy in early-stage endometrial carcinoma at intermediate/high risk of recurrence; c…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain [Phase 4]
A Phase 4 trial update describes using low-dose aspirin to reduce inflammation and prevent endometrial cancer in postmenopausal women with n…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Screening and Staging of Benign vs Malignant Pelvic Abnormalities
A Mayo Clinic study is currently recruiting to evaluate screening and staging of benign versus malignant pelvic abnormalities, including end…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma [Phase 2]
Clinical trial update for sacituzumab govitecan (IMMU-132) in endometrial carcinoma, a Phase 2 study currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma [Phase 2]
A Phase II, two-arm trial evaluating everolimus and letrozole with or without ribociclib (Lee011) in patients with advanced or recurrent end…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Pilot Window of Opportunity Trial (POET) [Phase 2]
This report provides an update on the Phase 2 Pilot Window of Opportunity Trial (POET) led by the University of Oklahoma, currently listed a…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: GYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk Endometrial Cancer [EARLY_Phase 1]
An EARLY Phase 1 clinical trial evaluating GYNORYLAQ-VLINIVAL, a Ψ-guided personalized neoantigen peptide vaccine, for high-risk endometrial…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Study of GV20-0251 in Participants With Solid Tumor Malignancies [Phase 1, Phase 2]
GV20 Therapeutics is evaluating GV20-0251 in a Phase 1/2 trial for adults with various solid tumors, and the study is currently recruiting. …
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors
This ClinicalTrials.gov entry describes a study examining pelvic floor dysfunction and quality of life in survivors of uterine cancers, incl…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer
A clinical trial is investigating patient-derived tumor-like cell clusters as a predictor of progesterone sensitivity in patients with early…
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia [Phase 2]
Phase 2 clinical trial evaluating a progesterone-based therapeutic regimen combined with statins for young women with early endometrial carc…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy
A clinical trial update examining changes in pelvic health, sexual function, and quality of life in women with pelvic cancers undergoing rad…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies [Phase 1, Phase 2]
This document reports a Phase 1/Phase 2 clinical trial evaluating GV20-0251 as monotherapy and in combination with pembrolizumab in several …
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Clinicopathological Analysis of Endometrial Carcinoma in the View of Old and New International Federation of Gynecology and Obestetrics (FIGO)
An ongoing Assiut University study investigating clinicopathological aspects of endometrial carcinoma in the context of old and new FIGO sta…
-
CLINICAL_TRIALS research · 2024-07-11Clinical Trial Update: Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia [Phase 2]
Phase 2 clinical trial evaluating medroxyprogesterone acetate plus atorvastatin in young women with atypical endometrial hyperplasia or earl…
-
CLINICAL_TRIALS research · 2015-02-20Clinical Trial Update: Improved Method of Detecting Cancer Metastases [NA]
The document provides an update on a clinical trial investigating an improved method for detecting metastases in endometrial carcinoma.
-
CLINICAL_TRIALS research · 2011-01-10Clinical Trial Update: Risk Factors for Concurrent Endometrial Carcinoma in Patients With a Curettage Diagnosis of Endometrial Hyperplasia
An update on a clinical trial investigating risk factors for concurrent endometrial carcinoma in patients with a curettage diagnosis of endo…